acne scar. Acne, unspecified
Conditions
Interventions
Intervention group: The treatment process during each session and in the intervals between sessions is of particular importance to enhance the accuracy and quality of the study. During treatment sessi
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Adult patients aged 18–65 years with moderate to severe acne scars Skin types I to IV according to the Fitzpatrick scale Bilateral facial involvement for conducting a split-face study No history of receiving laser treatment in the past at least 6 months
Exclusion criteria
Exclusion criteria: History of diabetes mellitus Active acne or recent use of isotretinoin Pregnancy or breastfeeding History of Kloids Patient with immunosuppressive conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of scar lesions. Timepoint: At baseline and at 1, 3, and 5 months after the intervention. Method of measurement: Assessment and evaluation of VisioFace images using the ECCA scoring system.;Severity of scar lesions. Timepoint: At baseline and at 1, 3, and 5 months after the intervention. Method of measurement: Assessment and evaluation of VisioFace images using the Goodman&Baron scoring system.;Patients’ quality of life. Timepoint: At baseline and at 1, 3, and 5 months after the intervention. Method of measurement: Assessment and questioning of patients according to the DLQI (Dermatology Life Quality Index) criteria. | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of adverse events. Timepoint: At each session. Method of measurement: Standardized forms for adverse events and imaging.;Skin tolerability. Timepoint: At each session. Method of measurement: Erythema and edema Pain scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Shahabaddin Daneshvar
Tehran University of Medical Sciences
Outcome results
None listed